<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36326054</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5207</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>45</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>The journal of physical chemistry. B</Title><ISOAbbreviation>J Phys Chem B</ISOAbbreviation></Journal><ArticleTitle>In Vitro Interaction of a C-Terminal Fragment of TDP-43 Protein with Human Serum Albumin Modulates Its Aggregation.</ArticleTitle><Pagination><StartPage>9137</StartPage><EndPage>9151</EndPage><MedlinePgn>9137-9151</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jpcb.2c04469</ELocationID><Abstract><AbstractText>An increased level of naturally occurring anti-TDP-43 antibodies was observed in the serum and cerebrospinal fluid (CSF) of amyotrophic lateral sclerosis patients. Human serum albumin (HSA), the most abundant protein in blood plasma and CSF, is found to interact with pathological proteins like A&#x3b2; and &#x3b1;-synuclein. Therefore, we examined the effect on the in vitro aggregation of a C-terminal fragment of TDP-43 in the presence of HSA. We found that the lag phase in TDP-43<sup>2C</sup> aggregation is abrogated in the presence of HSA, but there is an overall decreased aggregation as examined by thioflavin-T fluorescence spectroscopy and microscopy. An early onset of TDP-43<sup>2C</sup> oligomer formation in the presence of HSA was observed using atomic force microscopy and transmission electron microscopy. Also, a known chemical inhibitor of TDP-43<sup>2C</sup>aggregation, AIM4, abolishes the HSA-induced early formation of TDP-43<sup>2C</sup> oligomers. Notably, the aggregates of TDP-43<sup>2C</sup> formed in the presence of HSA are more stable against sarkosyl detergent. Using affinity copurification, we observed that HSA can bind to TDP-43<sup>2C</sup>, and biolayer interferometry further supported their physical interaction and suggested the binding affinity to be in sub-micromolar range. Taken together, the data support that HSA can interact with TDP-43<sup>2C</sup> in vitro and affect its aggregation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nirwal</LastName><ForeName>Sadhana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9523-5974</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saravanan</LastName><ForeName>Preethi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajpai</LastName><ForeName>Akarsh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meshram</LastName><ForeName>Vini D</ForeName><Initials>VD</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raju</LastName><ForeName>Gembali</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Hyderabad, Kandi Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeksha</LastName><ForeName>Waghela</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-0190-7777</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prabusankar</LastName><ForeName>Ganesan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Hyderabad, Kandi Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Basant K</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0001-9465-4803</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502284, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Phys Chem B</MedlineTA><NlmUniqueID>101157530</NlmUniqueID><ISSNLinking>1520-5207</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>ZIF514RVZR</RegistryNumber><NameOfSubstance UI="D000075462">Serum Albumin, Human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075462" MajorTopicYN="Y">Serum Albumin, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018625" MajorTopicYN="N">Microscopy, Atomic Force</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36326054</ArticleId><ArticleId IdType="doi">10.1021/acs.jpcb.2c04469</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>